Chinese Expert Consensus for the Management of Thrombocytopenia in Cirrhosis
Xiaoyuan Xu, Yujuan Guan, Jinghang Xu, Song Yang, Yifan Han, Jidong Jia, Yuemin Nan, Lai Wei, Zhongping Duan, Hui Zhuang, Liver Fibrosis, Cirrhosis and Portal Hypertension Group, Chinese Society of Hepatology, Chinese Medical Association
[ Html ]
[ PDF ] 516-523
doi:10.14218/JCTH.2025.00105
Oleanolic Acid Restores Drug Sensitivity in Sorafenib-resistant Hepatocellular Carcinoma: Evidence from In Vitro and In Vivo Studies
Tongtong Li, Xuan Shen, Tao Zhang, Jiaheng Ren, Wang Wang, Didi Wang, Pengxia Zhang
[ Html ]
[ PDF ] 469-483
doi:10.14218/JCTH.2024.00369
FTO Promotes Hepatocellular Carcinoma Progression by Mediating m6A Modification of BUB1 and Targeting TGF-βR1 to Activate the TGF-β Signaling Pathway
Lin Zhang, Li Gan, Yuru Lin, Zhechuan Mei, Shengtao Liao
[ Html ]
[ PDF ] 385-394
doi:10.14218/JCTH.2025.00007
Ketamine Hepatotoxicity: An Underappreciated Cause of Liver Damage - Analysis by RUCAM
Bianca Thakkar, George Y. Wu
[ Html ]
[ PDF ] 524-531
doi:10.14218/JCTH.2024.00478
Characteristics of a Chinese Cohort of Patients with Chronic Hepatitis C Infection (2019–2023) and a Case Report of Resistance-associated Substitutions to Sofosbuvir-velpatasvir Treatment
Hao Xiong, Shaokun Pan, Chaohui Zhou, Hong Shi, Youhua Xie, Jinsheng Guo
doi:10.14218/JCTH.2025.00033
Key Points and Future Directions from the 2024 Chinese Guidelines for Fatty Liver Disease
Maria Tampaki, Evangelos Cholongitas
[ Html ]
[ PDF ] 434-439
doi:10.14218/JCTH.2025.00051
Analysis of the Disease Spectrum Characteristics of Inherited Metabolic Liver Diseases in Two Hepatology Specialist Hospitals in Beijing over the Past 20 Years
Wei Hou, Yuanzhi Huang, Tang Shang, Zheng Wang, Wei Zhang, Kefi Wang, Yinjie Gao, Min Zhang, Sujun Zheng
[ Html ]
[ PDF ] 367-373
doi:10.14218/JCTH.2025.00030
Non-variceal Extrahepatic Portosystemic Shunts: A Review of Pathogenesis, Diagnosis, and Treatment
Nicole M. Anastasio, George Y. Wu
[ Html ]
[ PDF ] 425-433
doi:10.14218/JCTH.2024.00315
Investigation of HO-1 Regulation of Liver Fibrosis Related to Nonalcoholic Fatty Liver Disease Through the SIRT1/TGF-ß/Smad3 Pathway
Mengjiao Sun, Xiaoqing Wu, Zhandong Lin, Congyue Zhang, Jiawei Cui, Yaoyao Mao, Yue Shi, Jiaming Zhang, Yuemin Nan
[ Html ]
[ PDF ] 456-468
doi:10.14218/JCTH.2024.00481
Intestinal Depletion of TM6SF2 Exacerbates High-fat Diet-induced Metabolic Dysfunction-associated Steatotic Liver Disease through the Gut-liver Axis
Li-Zhen Chen, Yu-Rong Wang, Zhen-Zhen Zhao, Shou-Lin Zhao, Cong-Cong Min, Yong-Ning Xin
[ Html ]
[ PDF ] 443-455
doi:10.14218/JCTH.2024.00407
Improved Discrimination and Predictive Ability of Novel Prognostic Scores for Long-term Mortality in Hospitalized Patients with Cirrhosis
Sipu Wang, Gaoyue Guo, Han Wang, Xuqian Zhang, Wanting Yang, Jie Yang, Liping Wu, Chao Sun
[ Html ]
[ PDF ] 484-492
doi:10.14218/JCTH.2025.00004
Ursolic Acid Modulates Estrogen Conversion to Relieve Inflammation in Metabolic Dysfunction-associated Steatotic Liver Disease via HSD17B14
Simin Gu, Hui Zhang, Zhekun Xiong, Chong Chen, Junmin Wang, Dan Fang, Yiyuan Zheng, Yong Li
[ Html ]
[ PDF ] 269-277
doi:10.14218/JCTH.2024.00414